1. Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial. (June 2021) Authors: Chatzis, O.; Blanchard-Rohner, G.; Mondoulet, L.; Pelletier, B.; De Gea-Hominal, A.; Roux, M.; Huttner, A.; Hervé, P.L.; Rohr, M.; Matthey, A.; Gutknecht, G.; Lemaître, B.; Hayem, C.; Pham, H.T.; Wijagkanalan, W.; Lambert, P.H.; Benhamou, P.H.; Siegrist, C.A. Journal: Clinical microbiology and infection Issue: Volume 27:Number 6(2021) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗